Solventum Co. (NYSE:SOLV) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System trimmed its position in Solventum Co. (NYSE:SOLV) by 6.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 214,838 shares of the company’s stock after selling 14,229 shares during the quarter. California Public Employees Retirement System owned approximately 0.12% of Solventum worth $14,192,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Modus Advisors LLC acquired a new position in Solventum in the fourth quarter valued at approximately $25,000. Stonebridge Financial Group LLC acquired a new position in shares of Solventum in the 4th quarter valued at $26,000. Crews Bank & Trust acquired a new position in shares of Solventum in the 4th quarter valued at $32,000. Synergy Asset Management LLC purchased a new position in shares of Solventum in the 4th quarter valued at $35,000. Finally, Spire Wealth Management acquired a new stake in Solventum during the 4th quarter worth $37,000.

Analyst Upgrades and Downgrades

SOLV has been the topic of several research reports. Mizuho raised their price objective on Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a report on Monday, March 3rd. Morgan Stanley raised their price target on Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Wednesday, March 5th. Bank of America boosted their price objective on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research note on Wednesday, February 26th. The Goldman Sachs Group raised their target price on shares of Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a research report on Monday, March 3rd. Finally, Wells Fargo & Company increased their price target on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Solventum presently has a consensus rating of “Hold” and an average price target of $79.86.

Solventum Stock Performance

Shares of SOLV opened at $66.22 on Friday. The stock has a market capitalization of $11.45 billion and a P/E ratio of 24.08. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $85.92. The company’s fifty day moving average is $75.42 and its two-hundred day moving average is $71.95.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.